Our findings suggest a key function of both METTL3 and METTL14 in BlCa, which is further supported by heterogeneity and significant reduction of the heterodimeric catalytic core METTL3/METTL14 in MIBC and NMIBC compared to NUT. The gene discussed is METTL14; the disease is bladder transitional cell carcinoma.